Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank79
3Y CAGR-8.1%
5Y CAGR+19.7%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-8.1%/yr
vs +24.3%/yr prior
5Y CAGR
+19.7%/yr
Recent deceleration
Acceleration
-32.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
202511.60+31.0%
20248.86-28.1%
202312.32-17.6%
202214.95-0.1%
202114.97+216.5%
20204.73-5.9%
20195.03-19.7%
20186.26-19.2%
20177.75+161.8%
20162.96-